Search by Drug Name or NDC
NDC 50268-0647-14 Ondansetron 4 mg/5mL Details
Ondansetron 4 mg/5mL
Ondansetron is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is ONDANSETRON HYDROCHLORIDE.
MedlinePlus Drug Summary
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 50268-0647-14Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Ondansetron
Product Information
| NDC | 50268-0647 |
|---|---|
| Product ID | 50268-647_05cfabb7-5cc6-8905-e063-6394a90aeeb5 |
| Associated GPIs | |
| GCN Sequence Number | 028107 |
| GCN Sequence Number Description | ondansetron HCl SOLUTION 4 MG/5 ML ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 20040 |
| HICL Sequence Number | 006055 |
| HICL Sequence Number Description | ONDANSETRON HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ondansetron |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ondansetron |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/5mL |
| Substance Name | ONDANSETRON HYDROCHLORIDE |
| Labeler Name | AvPAK |
| Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091483 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50268-0647-14 (50268064714)
| NDC Package Code | 50268-647-14 |
|---|---|
| Billing NDC | 50268064714 |
| Package | 40 CUP, UNIT-DOSE in 1 TRAY (50268-647-14) / 5 mL in 1 CUP, UNIT-DOSE (50268-647-11) |
| Marketing Start Date | 2023-09-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |